Literature DB >> 7412595

Macrophage activation by muramyl dipeptide as measured by macrophage spreading and attachment.

A Tanaka, S Nagao, K Imai, R Mori.   

Abstract

A synthetic bacterial cell wall constituent, muramyl dipeptide (MDP), was found to induce the enhancement of macrophge spreading and attachment on glass or plastic surfaces. Macrophages exposed to bacterial lipopolysaccharide or lymphokine-containing cell supernatants showed similar enhancement. This finding supports the view that MDP activates macrophages. MDP was also found to enhance the viability of macrophages but to inhibit 3H-thymidine incorporation by macrophages.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7412595     DOI: 10.1111/j.1348-0421.1980.tb02858.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  10 in total

1.  Immunobiologically active lipid A analogs synthesized according to a revised structural model of natural lipid A.

Authors:  S Kotani; H Takada; M Tsujimoto; T Ogawa; K Harada; Y Mori; A Kawasaki; A Tanaka; S Nagao; S Tanaka
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

2.  Synthetic lipid A with endotoxic and related biological activities comparable to those of a natural lipid A from an Escherichia coli re-mutant.

Authors:  S Kotani; H Takada; M Tsujimoto; T Ogawa; I Takahashi; T Ikeda; K Otsuka; H Shimauchi; N Kasai; J Mashimo
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

3.  Polymorphonuclear leukocyte activation by a synthetic muramyl dipeptide analog.

Authors:  Y Osada; T Otani; M Sato; T Une; K Matsumoto; H Ogawa
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

4.  Enhancement of dengue virus type 2 replication in mouse macrophage cultures by bacterial cell walls, peptidoglycans, and a polymer of peptidoglycan subunits.

Authors:  H Hotta; S Hotta; H Takada; S Kotani; S Tanaka; M Ohki
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

5.  Epithelioid granuloma formation requiring no T-cell function.

Authors:  A Tanaka; K Emori; S Nagao; K Kushima; O Kohashi; M Saitoh; T Kataoka
Journal:  Am J Pathol       Date:  1982-02       Impact factor: 4.307

6.  Stimulation of complement production in mice by N alpha-(N-acetylmuramyl-L-alanyl-D-isoglutamine)-N epsilon-stearoyl-L-lysine.

Authors:  N Endo; T Okuda; Y Osada; H Zen-Yoji
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

7.  Stimulation of migration of human monocytes by bacterial cell walls and muramyl peptides.

Authors:  T Ogawa; S Kotani; K Fukuda; Y Tsukamoto; M Mori; S Kusumoto; T Shiba
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

8.  Granuloma formation by muramyl dipeptide associated with branched fatty acids, a structure probably essential for tubercle formation by Mycobacterium tuberculosis.

Authors:  K Emori; S Nagao; N Shigematsu; S Kotani; M Tsujimoto; T Shiba; S Kusumoto; A Tanaka
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

9.  Chronic hypersensitivity pneumonitis produced in the rabbit by the adjuvant effect of inhaled muramyl dipeptide (MDP).

Authors:  H B Richerson; M T Suelzer; P A Swanson; J E Butler; W C Kopp; E F Rose
Journal:  Am J Pathol       Date:  1982-03       Impact factor: 4.307

10.  Effect of L18-MDP(Ala), a synthetic derivative of muramyl dipeptide, on nonspecific resistance of mice to microbial infections.

Authors:  Y Osada; M Mitsuyama; T Une; K Matsumoto; T Otani; M Satoh; H Ogawa; K Nomoto
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.